TransMed Systems

company

About

TransMed Systems is a leading developer of software solutions that facilitate exploration, reporting and analysis of clinical healthcare

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.10M
Industries
Clinical Trials,Information Technology,Software
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

TransMed Systems develops and deploys software solutions that facilitate exploration, reporting, and analysis of clinical, molecular, and healthcare operational data. TransMed's BIS provides an integrated bio-informatics platform enabling clinical and research organizations to aggregate data from multiple sources, easily explore data, and perform research and/or practice specific analysis. TransMed's platform unlocks the potential of the healthcare repository by tightly integrating analytics with aggregated data providing self-service analysis of all bio-clinical data sources in a framework usable by clinicians and investigators. Our solutions are used by health sciences researchers as well as clinicians interested in the application of information technology to the challenges of basic research and turning research into improved clinical practices. Our Bioinformatics solution is composed of four core capabilities leveraging our meta-data driven repository that aggregates data from disparate health data sources.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.10M
TransMed Systems has raised a total of $1.10M in funding over 2 rounds. Their latest funding was raised on Aug 9, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 9, 2012 Grant $1.10M 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
TransMed Systems is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant